Incox
Oral antiangiogenic, powerful and selective inhibitor of tyrosine kinase of endothelial growth factor receptors (VEGFR). Indicated to treat adult patients with advanced renal cells cancer.
Therapeutic Area
Uro-Oncology
Active Ingredient
Axitinib
Line
Oncology
Pharmaceutical Forms
1 mg x 56 coated tablets
5 mg x 56 coated tablets
